Condition: Adult Double Unit Cord Blood Transplant · Sponsor: Seoul National University Hospital
The efficacy and safety of non-myeloablative and myeloablative preconditioning followed by dual-unit umbilical cord blood transplantation from unrelated donors in adult patients with malignant hematologic diseases eligible for allogeneic hematopoietic stem cell transplantation are evaluated through prospective observation and analysis of actual clinical data collection
This description comes directly from the study's public registry record.
Dong-Yeop Shin, MD, PhD. · +82-2-2072-7209 · shindongyeop@snu.ac.kr
Always discuss trial participation with your own doctor first.
| Jeonbuk National University Hopital | Jeonju, Jeonlabuk-do, South Korea | Not Yet Recruiting |
| Keimyung Unversity Dongsan Hospital | Daegu, South Korea | Not Yet Recruiting |
| Dong-A University Hospital | Pusan, South Korea | Not Yet Recruiting |
| Pusan National University Hospital | Pusan, South Korea | Not Yet Recruiting |
| Seoul National University Bundang Hospital | Seongnam, South Korea | Not Yet Recruiting |
| Seoul National University Hospital | Seoul, South Korea | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06712108